Critical Role of Indoleamine 2,3-Dioxygenase in Tumor Resistance to Repeated Treatments With Targeted IFN

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0538
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Central Role of IFN -Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12-Mediated Antitumor Immunity

Cancer Research
Cancer ResearchOncology
2009English

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth With Ethyl Pyruvate

Cancer Research
Cancer ResearchOncology
2010English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Antioxidants Inhibit Indoleamine 2,3-Dioxygenase in IFN- -Activated Human Macrophages: Posttranslational Regulation by Pyrrolidine Dithiocarbamate

Journal of Immunology
AllergyImmunology
2001English

Inhibition of Experimental Asthma by Indoleamine 2,3-Dioxygenase

Journal of Clinical Investigation
Medicine
2004English

Induction of Pulmonary Indoleamine 2,3-Dioxygenase by Interferon.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy